Skip to main content

Table 2 Atrial fibrillation or atrial flutter characteristics of study patients

From: Analysis of clinical risk factors of failed electrical cardioversion in patients with persistent atrial fibrillation or atrial flutter

Variable

Group 1

Group 2

Group 3

p value

(N = 73)

(N = 146)

(N = 29)

Form of AF or AFL

   

0.252

 AF

68 (93)

135 (93)

29 (100)

 

 AFL

3 (4)

2 (1)

  

 AF and AFL (mixed)

2 (3)

9 (6)

0 (0)

 

Duration of AF or AFL

  

0 (0)

0.000

 Less than 1 year

48 (66)

53 (36)

  

 From 1 to 2 year

10 (14)

16 (11)

6 (21)

 

 From 2 to 5 year

10 (14)

32 (22)

6 (21)

 

 From 5 to 10 year

1 (1)

16 (11)

9 (31)

 

 Over 10 year

0 (0)

8 (6)

3 (10)

 

 Unidentified

4 (6)

21 (14)

2 (7)

 

Duration of anticoagulation

  

3 (10)

0.886

 Under 1 month

10 (14)

16 (11)

4 (14)

 

 From 1 to 2 month

14 (19)

23 (16)

6 (21)

 

 Over 2 month

48 (66)

102 (70)

19 (66)

 

 None

1 (1)

5 (3)

0 (0)

 

 MACE (%)

1 (1)

8 (6)

2 (7)

0.300

  1. Values are presented as n (%). AF atrial fibrillation, AFL atrial flutter, MACE major adverse cardiovascular event